January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...
January 19, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's latest ...
Behavioral science is being applied in unique ways for enterprise-imaging product design. Behavioral science is the ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
January 18, 2023 — the Society for Cardiovascular Angiography & Interventions (SCAI) announced four recipients of their ...
January 18, 2023 — Phone calls from a nurse may improve survival for patients treated for heart failure, according to a ...
According to the U.S. Centers for Disease Control and Prevention (CDC), one person dies every 37 seconds in the United ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
January 17, 2023 — Arterial hypertension(AH), or high blood pressure, can be prevented if diagnosed pre-clinically on ...
January 17, 2023 — Ischemic stroke, or cerebral infarction, ranks first in prevalence among diseases that lead to death ...
January 16, 2023 — On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
January 13, 2023 — BioSig Technologies, Inc., an advanced digital signal processing technology company delivering ...
January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...
January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...
January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA ...
January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...
January 19, 2023
